TuHURA Biosciences (STU:PL3) Tariff Resilience Score: 5/10 (As of Jun. 30, 2026)


STU:PL3 TuHURA Biosciences Inc STU:PL3
14 GF Score
Price €1.96
! 1 Warning Sign
View Full Analysis

What is TuHURA Biosciences Tariff Resilience Score?

TuHURA Biosciences STU:PL3 +0.51% 14 Tariff Resilience Score is 5 as of Jun. 30, 2026. GuruFocus rates STU:PL3 with a GF Score™ of 14/100. The stock has 1 warning sign investors should review. Among 1,375 Biotechnology companies, TuHURA Biosciences ranks better than 62.25% on this metric.

TuHURA Biosciences has the Tariff Resilience Score of 5, which implies that the company might have Average Resilient.

TuHURA Biosciences has Biotech firm with potential exposure to tariffs on research materials. Limited international sales but reliant on global supply chains for R&D inputs.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes TuHURA Biosciences might have Average Resilient.

TuHURA Biosciences  (STU:PL3) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

TuHURA Biosciences Tariff Resilience Score Related Terms

STU:PL3 vs ACOG, MENS, ENLV: Tariff Resilience Score Comparison

For the Biotechnology subindustry, TuHURA Biosciences's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TuHURA Biosciences Tariff Resilience Score vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, TuHURA Biosciences's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where TuHURA Biosciences's Tariff Resilience Score falls into.


STU:PL3
14GF Score
TuHURA Biosciences Inc STU:PL3
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 5 mean?
TuHURA Biosciences (STU:PL3) has a Tariff Resilience Score of 5 as of Jun. 30, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, TuHURA Biosciences ranks #519 out of 1375 companies in the Biotechnology industry, placing it in the top 37.7%.
Is TuHURA Biosciences' Tariff Resilience Score too high?
TuHURA Biosciences' current Tariff Resilience Score is 5. The Biotechnology industry median Tariff Resilience Score is 4.00. TuHURA Biosciences' value of 5 is 25% above this industry median. Based on the distribution chart, TuHURA Biosciences ranks #519 out of 1375 companies in the Biotechnology industry, which is above the industry midpoint. Overall, TuHURA Biosciences has a GF Score™ of 14/100, reflecting its overall financial health beyond just this single metric.
How does TuHURA Biosciences' Tariff Resilience Score compare to ACOG and MENS?
According to the Biotechnology industry distribution chart, TuHURA Biosciences ranks #519 out of 1375 companies for Tariff Resilience Score. This puts TuHURA Biosciences in the upper half of its industry. The industry median Tariff Resilience Score is 4.00. TuHURA Biosciences' value of 5 is 25% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Biotechnology company?
The median Tariff Resilience Score among Biotechnology companies is 4.00, based on 1,375 companies in the industry. Companies in the top quartile (top 25%) have a Tariff Resilience Score significantly above this median, while those in the bottom quartile fall well below. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. TuHURA Biosciences's current Tariff Resilience Score of 5 is 25% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. For the Biotechnology industry, the median Tariff Resilience Score is 4.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TuHURA Biosciences's current Tariff Resilience Score is 5. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TuHURA Biosciences stock overvalued right now?
TuHURA Biosciences (STU:PL3) has a current Tariff Resilience Score of 5. The current Tariff Resilience Score is 5 and 25% above the Biotechnology industry median of 4.00. TuHURA Biosciences' overall GF Score™ is 14/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For TuHURA Biosciences (STU:PL3), the current Tariff Resilience Score is 5 as of Jun. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

TuHURA Biosciences Business Description

Other Exchanges HURA:USA
Address 10500 University Center Drive, Suite 110, Tampa, FL, USA, 33612
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
14GF Score

Get the complete analysis for STU:PL3

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.96
Price